Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 29:3:39.
doi: 10.12688/wellcomeopenres.14439.2. eCollection 2018.

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya

Maureen Njue  1   2 , Patricia Njuguna  1   3 , Melissa C Kapulu  1   4 , Gladys Sanga  1 , Philip Bejon  1   4 , Vicki Marsh  1   4 , Sassy Molyneux  1   4 , Dorcas Kamuya  1
Affiliations

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya

Maureen Njue et al. Wellcome Open Res. .

Abstract

Background: The range and amount of volunteer infection studies, known as Controlled Human Infection Model (CHMI) studies, in Low-Middle Income Countries (LMICs) is increasing with rapid technological advancement, world-class laboratory facilities and increasing capacity development initiatives. However, the ethical issues these studies present in LMICs have not been empirically studied. We present findings of a descriptive social science study nested within a malaria volunteer infection study, on-going at the time of writing, at the KEMRI-Wellcome Trust Research Programme (KWTRP) on the Kenyan Coast. Methods: The study included non-participant observations, five group discussions with more than half of the CHMI study participants, two in-depth interviews with study team members, and an exit questionnaire administered to the participants. Results: Participants understood the key elements of the study, including that they would be deliberately infected with malaria parasites and may get malaria as a result, there would be regular blood draws, and they would spend up to 24 days in a residence facility away from their homes. The greatest motivation for participation was the monetary compensation of 20 USD per overnight stay given as a lump-sum at the end of their residency stay. Also appreciated were the health screening tests prior to enrolment and the positive relations with the study team. Concerns raised included the amount and regularity of blood draws experienced, and concerns that this type of research may feed into on-going rumours about research generally. Conclusion: With the increasing range and number of CHMI studies being conducted in LMICs, current ethical guidance are inadequate. This study highlights some of the ethical issues that could emerge in these settings, emphasizing the heavy responsibility placed on research review and regulatory systems, researchers and funders, as well as the importance of carefully tailored community engagement and consent processes.

Keywords: CHMI Volunteer Infection studies; Ethics; developing countries; informed consent; malaria; risks.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

References

    1. Hodgson SH, Juma E, Salim A, et al. : Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya. Malar J. 2015;14:182. 10.1186/s12936-015-0671-x - DOI - PMC - PubMed
    1. Shekalaghe S, Rutaihwa M, Billingsley PF, et al. : Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg. 2014;91(3):471–80. 10.4269/ajtmh.14-0119 - DOI - PMC - PubMed
    1. Spring M, Polhemus M, Ockenhouse C: Controlled human malaria infection. J Infect Dis. 2014;209 Suppl 2:S40–5. 10.1093/infdis/jiu063 - DOI - PubMed
    1. Miller FG, Grady C: The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis. 2001;33(7):1028–33. 10.1086/322664 - DOI - PubMed
    1. Agnandji ST, Huttner A, Zinser ME, et al. : Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. N Engl J Med. 2016;374(17):1647–60. 10.1056/NEJMoa1502924 - DOI - PMC - PubMed

LinkOut - more resources